Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

←Back to companies

CCC · NZX

Cooks Coffee Company (CCC)

Consumer / Cafe and coffee franchising•Covered: FY22 - FY26•6 published briefings

Cooks Coffee Company is an NZX-listed consumer / cafe and coffee franchising company with FY22 - FY26 of published result briefings.

Latest briefing

FY26 · Released 29 May 2026

Revenue up 83.7% but PBT and NPAT both fell 62.5% to NZ$0.3m

EBITDA stayed essentially flat at NZ$1.3m while cash dropped 58.2% to NZ$1.1m on debt repayment and elevated working-capital absorption.

Market data

Latest available
Price
NZD 0.19
Mkt cap
$12.9m
Yield
0%

Quote as of 05-06-2026 10:00am NZT

Sections⌄
  1. Snapshot
  2. Chat
  3. Longitudinal View
  4. Follow-through
  5. Archive
  6. Related Insights
  1. Snapshot
  2. Chat
  3. Longitudinal View
  4. Follow-through
  5. Archive
  6. Related Insights

Snapshot

Latest metrics

FY26, released 29 May 2026

← Swipe to view more
CCC latest metrics
MetricValueChange
Revenue$12.4m↑ +164.8%
EBITDA$1.3m↑ +225.2%
NPAT$0.3m↑ +104.7%
Operating cash flow$0.5m↓ -27.1%
OCF / EBITDA %38.1%↓ -131.9pp
Net debt$1.7m↓ -6.7%
Net debt / EBITDA1.34xOutside range lowOutside range low net debt / ebitda. 1.33x; 3-period range 2.77x to 4.65x. Net debt / EBITDA: 1.33x, below normal range; 3-period mean 3.67x, range 2.77x-4.65x.↓ -71.2%
ROE %-13.5%↓ -172.4pp
DPS0.0c—
PBT$0.3m↑ +184.3%

Source: latest published briefing (FY26, released 29 May 2026). Change compares against the prior equivalent period: FY24, released 30 May 2024.

Chat

Ask about CCC

Ask follow-up questions about Cooks Coffee Company's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about CCC

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more
CCC metric history
MetricFY2612 MONTHS29 May 2026FY2412 MONTHS30 May 2024HY246 MONTHS30 November 2023FY2312 MONTHS30 May 2023HY236 MONTHS29 November 2022FY2212 MONTHS30 May 2022Trend
Revenue$12.4m$4.7m$2m$6.6m$3.1m$6.6m
Chart
Revenue growth %83.7%-29.4%Outside range lowOutside range low revenue growth. -29.4%; 3-period range 0.7% to 283.3%. Revenue growth: -29.4%, below normal range; 3-period mean 122.6%, range 0.7%-283.3%.-34.2%0.7%-15.4%283.3%Outside range highOutside range high revenue growth. 283.3%; 3-period range -29.4% to 83.7%. Revenue growth: 283.3%, above normal range; 3-period mean 18.3%, range -29.4%-83.7%.
Chart
  • FY24 Revenue growth %: Outside range low revenue growth. -29.4%; 3-period range 0.7% to 283.3%. Revenue growth: -29.4%, below normal range; 3-period mean 122.6%, range 0.7%-283.3%.
EBITDA$1.3m$0.4m—$0.75m$0.49m$0.76m
Chart
EBITDA margin %10.5%8.6%Outside range lowOutside range low ebitda margin. 8.6%; 3-period range 10.5% to 11.5%. EBITDA margin: 8.6%, below normal range; 3-period mean 11.1%, range 10.5%-11.5%.—11.3%15.7%11.5%Outside range highOutside range high ebitda margin. 11.5%; 3-period range 8.6% to 11.3%. EBITDA margin: 11.5%, above normal range; 3-period mean 10.2%, range 8.6%-11.3%.
Chart
  • FY22 EBITDA margin %: Outside range high ebitda margin. 11.5%; 3-period range 8.6% to 11.3%. EBITDA margin: 11.5%, above normal range; 3-period mean 10.2%, range 8.6%-11.3%.
  • FY24 EBITDA margin %: Outside range low ebitda margin. 8.6%; 3-period range 10.5% to 11.5%. EBITDA margin: 8.6%, below normal range; 3-period mean 11.1%, range 10.5%-11.5%.
PBT$0.3m-$0.36m-$0.05m-$3.2m$0.1m$0.6m
Chart
PBT growth %-62.5%———0.0%—
Chart
NPAT$0.3m-$6.4m-$5.6m-$3.2m$0.1m$0.3m
Chart
NPAT growth %-62.5%———0.0%—
Chart
Operating cash flow$0.5m$0.68m$0.33m-$0.48m-$0.03m-$0.1m
Chart
OCF / EBITDA %38.1%170.0%Outside range highOutside range high ocf / ebitda cash conversion. 170%; 3-period range -64.5% to 38.1%. OCF / EBITDA cash conversion: 170.0%, above normal range; 3-period mean -13.0%, range -64.5%-38.1%.—-64.5%-5.3%-12.6%
Chart
  • FY24 OCF / EBITDA %: Outside range high ocf / ebitda cash conversion. 170%; 3-period range -64.5% to 38.1%. OCF / EBITDA cash conversion: 170.0%, above normal range; 3-period mean -13.0%, range -64.5%-38.1%.
FCF pre-lease——$0.32m—-$0.03m—
Chart
FCF post-lease————-$0.03m—
—
DPS0.0c0.0c————
Chart
ROE %-13.5%158.9%155.9%-226.8%3.5%9.8%
Chart
Net debt$1.7m$1.9m—$2.7m—$2.1m
Chart
Net debt / EBITDA1.34xOutside range lowOutside range low net debt / ebitda. 1.33x; 3-period range 2.77x to 4.65x. Net debt / EBITDA: 1.33x, below normal range; 3-period mean 3.67x, range 2.77x-4.65x.4.65xOutside range highOutside range high net debt / ebitda. 4.65x; 3-period range 1.33x to 3.6x. Net debt / EBITDA: 4.65x, above normal range; 3-period mean 2.57x, range 1.33x-3.60x.—3.59x—2.77x
Chart
  • FY24 Net debt / EBITDA: Outside range high net debt / ebitda. 4.65x; 3-period range 1.33x to 3.6x. Net debt / EBITDA: 4.65x, above normal range; 3-period mean 2.57x, range 1.33x-3.60x.
  • FY26 Net debt / EBITDA: Outside range low net debt / ebitda. 1.33x; 3-period range 2.77x to 4.65x. Net debt / EBITDA: 1.33x, below normal range; 3-period mean 3.67x, range 2.77x-4.65x.
Debtor days68Outside range lowOutside range low debtor days. 68d; 3-period range 72d to 134d. Debtor days: 67.5 days, below normal range; 3-period mean 93.3 days, range 72.4 days-134.3 days.134Outside range highOutside range high debtor days. 134d; 3-period range 68d to 73d. Debtor days: 134.3 days, above normal range; 3-period mean 71.0 days, range 67.5 days-73.0 days.111738172
Chart
  • FY24 Debtor days: Outside range high debtor days. 134d; 3-period range 68d to 73d. Debtor days: 134.3 days, above normal range; 3-period mean 71.0 days, range 67.5 days-73.0 days.
  • FY26 Debtor days: Outside range low debtor days. 68d; 3-period range 72d to 134d. Debtor days: 67.5 days, below normal range; 3-period mean 93.3 days, range 72.4 days-134.3 days.
Total assets$35.2m$29.3m$25.4m$33.9m$36.9m$35.1m
Chart

Reference: annolyse.ai/companies/ccc

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

↗
Loading chart...
  • FY22 CCC: Outside range low operating working-capital movement. $-3.7m; 3-period range $0m to $0.7m. Operating working-capital movement: NZ$-3.7m, below normal range; 2/3 prior periods had builds averaging NZ$0.6m, and none had a working-capital release.
  • FY26 CCC: Outside range high operating working-capital movement. $0.7m; 3-period range $-3.7m to $0.4m. Operating working-capital movement: NZ$0.7m, above normal range; 1/3 prior periods had builds averaging NZ$0.4m, and 1 had releases averaging NZ$-3.7m.

The setup & the reality

FY24 → FY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Current result now available

FY26 · Released 29 May 2026

Revenue up 83.7% but PBT and NPAT both fell 62.5% to NZ$0.3m

EBITDA stayed essentially flat at NZ$1.3m while cash dropped 58.2% to NZ$1.1m on debt repayment and elevated working-capital absorption.

Read latest briefing→

Historical setup

What FY24 said to watch

From NZ exit write-off of NZ$6.0m drives equity to negative NZ$4.0m

No prior EBITDA comparable, no forward revenue guidance, and no quantified FY25 target are supplied; the only forward marker is a stated FY34 ambition of 305 stores in UK & Ireland, against a current footprint implied by the cited NZ$58.2m of aggregate franchisee sales. There is therefore no near-term yardstick against which to test execution beyond store-sales growth rates.

The HY24 split shows revenue at 43.7% of the full year and continuing-operations momentum extending into the second half, consistent with the second-half-weighted shape management describes. The release does not, however, support any read-through to FY25 cost base or impairment risk.

Open questions

Open questions from FY24

  • How does the board intend to address the negative equity position, and is a capital raise or shareholder support arrangement contemplated in FY25?
  • What was the size of the receivables impairment that EBITDA is stated "before", and what does it imply about franchisee health?
  • Why have debtor days risen from 73 to 134, and what changes to franchisee credit terms or collection processes are being made?
  • Can management reconcile the stated 19% revenue growth on store-correlated revenue with the reported decline from NZ$6.6m to NZ$4.7m on a like-for-like basis?
  • What is the funding plan and covenant position on the NZ$3.0m of gross borrowings given the negative equity outcome?

This briefing cannot assess solvency, going-concern status, banking-covenant headroom, or the recoverability of trade receivables, because none of those items are quantified in the supplied materials.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

FY26 · Released 29 May 2026

Revenue up 83.7% but PBT and NPAT both fell 62.5% to NZ$0.3m

EBITDA stayed essentially flat at NZ$1.3m while cash dropped 58.2% to NZ$1.1m on debt repayment and elevated working-capital absorption.

Read briefing→

FY24 · Released 30 May 2024

NZ exit write-off of NZ$6.0m drives equity to negative NZ$4.0m

Continuing-operations PBT loss narrowed 88.9% to NZ$0.4m and operating cash flow turned positive, but the discontinued NZ operation pushed equity

Read briefing→

HY24 · Released 30 November 2023

Equity turned negative as discontinued unit booked NZ$5.3m loss

UK & Ireland franchising profit rose to NZ$0.8m, but reported revenue fell 34.2% and shareholders' equity swung to -NZ$3.6m.

Read briefing→

FY23 · Released 30 May 2023

FY23 NPAT swung to a $3.2m loss as below-EBITDA charges crushed thin trading

Positive EBITDA of $0.75m was overwhelmed by impairments, D&A and interest, leaving cash at $0.4m and equity halved to $1.4m.

Read briefing→

HY23 · Released 29 November 2022

Operating cash swung to outflow as headline PBT held flat

Reported profit barely moved but cash generation evaporated, even as the balance sheet flipped from negative to positive equity.

Read briefing→

FY22 · Released 30 May 2022

Revenue tripled on UK reopening but H2 burned $1.5m of cash

Profit and net debt both improved, yet operating cash flow turned negative as a second-half cash burn reversed a strong first half.

Read briefing→

Related insights

Compare this company

The latest CCC metrics also appear in these cross-company views.

Insight

Cash conversion quality

This result converted 38.1% of EBITDA to operating cash flow.

Open insight→

Insight

Revenue growth context

Revenue growth was 83.7% for this reporting period.

Open insight→

Insight

Leverage and balance-sheet risk

Net debt / EBITDA is 1.33x for this result.

Open insight→

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 0.0pp.

Open insight→

Get notified when CCC publishes

Get the next Cooks Coffee Company result briefing and five-year history updates by email.